BioPlus Acquisition Corp. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
BioPlus Acquisition Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q2 2023.
  • BioPlus Acquisition Corp. Operating Income (Loss) for the quarter ending June 30, 2023 was -$1.28M, a 401% decline year-over-year.
  • BioPlus Acquisition Corp. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$2.16M, a 207% decline year-over-year.
  • BioPlus Acquisition Corp. annual Operating Income (Loss) for 2022 was -$1.17M, a 687% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$2.16M -$1.28M -$1.02M -401% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$1.14M -$275K +$31.9K +10.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$1.17M -$318K -$176K -124% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$995K -$290K -$289K -33009% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 -$705K -$255K -$254K -22306% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$451K -$307K -$302K -6044% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$149K -$142K Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$877 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$1.14K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$5K Feb 11, 2021 Mar 31, 2021 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.